NCCN Announces Research Funding for Biomarker-Directed Therapy in Metastatic Colorectal Cancer, in Collaboration with Fight CRC and Pfizer

/PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced new grants awarded to improve quality...

Related Keywords

Staceya Cohen ,Anjee Davis ,Amit Mahipal ,Melissa Lumish ,Vanessa Wookey ,Faisal Mehmud ,Pfizer ,Case Comprehensive Cancer Center ,National Comprehensive Cancer Network ,Oncology Research Program ,Fred Hutchinson Cancer Center ,Scientific Review Committee ,Fox Chase Cancer Center ,Wide Initiative To Increase Access Biomarker ,National Comprehensive Cancer Network Oncology Research Program ,Pfizer Inc ,University Hospitals Seidman Cancer Center ,Colorectal Cancer ,Senior Vice President ,Chief Scientific Officer ,Fred Hutchinson Cancer ,Rapid Assessment ,Molecular Profiling ,Metastatic Colorectal Cancer ,Liquid Biopsy ,University Hospitals Seidman Cancer ,Evidence Based Therapy ,System Wide Initiative ,Increase Access ,Biomarker Driven Therapy ,Fox Chase Cancer ,Biomarker Testing ,Precision Medicine ,Early Pipeline Lead ,Fight Colorectal Cancer ,National Comprehensive Cancer ,Practice Guidelines ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Financing Agreements ,Not For Profit ,